İAİsmail Hakkı Akbeyaz

İsmail Hakkı Akbeyaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


İsmail Hakkı Akbeyaz has a total of 228 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • How Effective Is Presymptomatic Treatment? Longitudinal Real-World Outcomes with Nusinersen in Spinal Muscular Atrophy Patients with Two SMN2 Copies

    by İsmail Hakkı Akbeyaz, Gülten Öztürk, Elif Acar Arslan, Gülnur Özel, Evrim Karadağ Saygı, Olcay Ünver, Dilşad Türkdoğan

  • Extreme ambient temperatures and seizure outcomes in children with epilepsy: insights from a survey in Turkey

    by Ismail Hakki Akbeyaz, Yekta Culpan, Seyhmus Gavas, Gulten Ozturk, Bilgihan Bikmazer, Zeynep Yilmaz, Bilgen B. Geckinli, James M. Mills, Francesco Fortunato, Dilsad Turkdogan, et al.

  • Open Access

    Personalized Management and Timing of Thymectomy in Juvenile Myasthenia Gravis: Insights from Routine Clinical Scale Use in a Single-Center Retrospective Cohort—A Case Series

    by Gulten Ozturk, Olcay Unver, Elif Acar Arslan, Nezih Onur Ermerak, Bilgihan Bıkmazer, Hakkı Akbeyaz, Burcu Karakayali, Sermin Aksoy Ozcan, Gulcan Akyuz, Pınar Ergenekon, et al.

    Introduction: Juvenile myasthenia gravis (JMG) is a rare autoimmune disorder with a variable clinical course and limited pediatric-specific treatment guidelines. Objective clinical scales, such as the Quantitative Myasthenia Gravis (QMG) Score and the Pediatric Myasthenia Gravis Quality of Life 15 (PM-QOL15), may support individualized management, but their role in routine practice remains underexplored. Methods: We retrospectively reviewed 10 seropositive JMG patients followed at a single tertiary neuromuscular clinic between 2014 and 2024. All patients underwent a systematic assessment with QMG at each visit, while PM-QOL15 was administered at the final visit. Clinical data, comorbidities, antibody status, treatment modalities, and outcomes were analyzed. Associations between treatment strategies, comorbidities, and scale scores were explored using appropriate statistical methods. Results: Seven patients (70%) underwent thymectomy, resulting in a reduction in mean QMG scores from 7.7 to 2.4, though residual relapses were observed. Chronic intravenous immunoglobulin (IVIG) therapy, administered to 70% of patients, did not significantly reduce relapse rates or steroid exposure and was associated with higher QMG scores in the second year, suggesting use in more severe phenotypes rather than therapeutic efficacy. Prolonged corticosteroid therapy did not improve remission time or relapse frequency and was complicated by major adverse effects in two patients. Timing of azathioprine initiation showed no significant correlation with relapse frequency. PM-QOL15 correlated strongly with mean QMG (r = 0.88, p < 0.001), reflecting cumulative disease burden. Patients with comorbidities required longer stabilization, although differences were not statistically significant. Conclusions: The routine integration of QMG and PM-QOL15 into follow-up may facilitate the earlier recognition of subclinical deterioration, provide objective measures of treatment response, and guide personalized management in JMG. Thymectomy showed benefit in selected patients, while the long-term roles of IVIG and corticosteroids remain uncertain. Larger multicenter prospective studies are warranted to confirm these findings and refine evidence-based strategies for pediatric JMG.

  • Open Access

    Kohlschütter-Tönz Syndrome: A Rare Clinical Entity with Amelogenesis Imperfecta in Two Siblings, Dental Management and Scoping Review

    by Ecem Akbeyaz Şivet, İsmail Hakkı Akbeyaz, Gülcan Berkel, Ahmet Yeşilyurt, Berkant Sezer, Ali Menteş

    Kohlschütter-Tönz syndrome (KTS) (OMIM#226750) is a rare autosomal recessive disorder characterized by epileptic encephalopathy, developmental delay, and amelogenesis imperfecta. Early diagnosis and management are crucial, but the complexity of symptoms, particularly dental and neurological impairments, poses significant challenges. The aim of this report is to describe the clinical findings of 2 siblings and their dental management, whose dental examination led to genetic referral and subsequent diagnosis of KTS. Dental examinations revealed enamel defects consistent with amelogenesis imperfecta, including yellow-brown discoloration, soft enamel, and diastemas in both siblings. The younger sibling, a 9-year-old boy, exhibited early-onset seizures, intellectual disability, spasticity, and a history of kidney stones. The older sibling, a 13-year-old boy, presented with more severe neurodevelopmental delay, early-onset seizures, and drug-resistant epilepsy. Genetic testing confirmed homozygous deletions in the ROGDI gene, leading to the diagnosis of KTS in both siblings. The younger sibling received successful restorative treatment under general anesthesia, while the older sibling’s oral care was managed conservatively due to contraindications for general anesthesia. These cases underscore the importance of pediatric dentists in the early identification of rare genetic disorders such as KTS, especially when dental anomalies like amelogenesis imperfecta are present. Timely referral for genetic evaluation can facilitate accurate diagnosis and appropriate care planning. Moreover, sharing clinical experiences and treatment outcomes contributes to a better understanding of this rare syndrome and helps guide future diagnostic and therapeutic strategies. Cite this article as: Akbeyaz Şivet E, Akbeyaz İH, Berkel G, Yeşilyurt A, Sezer B, Menteş A. KohlschütterTönz syndrome: A rare clinical entity with amelogenesis imperfecta in two siblings, dental management and scoping review. Turk Arch Pediatr. 2025;60(5):546-551.

  • DNA Tamir Bozuklukları ve Görüntüleme Bulguları

    by İsmail Hakkı Akbeyaz, Özge Yapıcı, Olcay Ünver

  • Open Access

    Canpolat&Karaman&Kardaş - Temel Pediatrik Nöroradyoloji Nörometabolik ve Heredodejeneratif Hastalıklarda Klinik ve Radyolojik Yaklaşım

    by Niyazi Acer, Özge Coşkun Sağlam, Hatice Yenigül, Cansu Kibar Karagöz, Şadan Tutuş, Hüseyin Tan, Aziz Anıl Tan, Özlem Özkale Yavuz, Ezgi Çağlar, Barış Ten, et al.

  • Unclear symptoms, early diagnosis and perfect outcome: a case diagnosed as sepiapterin reductase deficiency hidden behind vitamin B12 deficiency

    by İsmail Hakkı Akbeyaz, Olcay Ünver, Gülten Öztürk, Burcu Öztürk Hişmi, Akif Ayaz, Kürşad Aydın, Dilşad Türkdoğan

    Objectives: Sepiapterin reductase deficiency (SRD) is a rare dopa-sensitive neurotransmitter disorder caused by autosomal recessive mutations in the sepiapterin reductase gene. The triad of paroxysmal stiffening, oculogyric crises, and hypotonia are highly suggestive in some patients. However, in other patients, the clinical picture may be nonspecific and remain under-recognized and misdiagnosed as cerebral palsy. Case presentation: We present a nine-month-old boy who initially presented with hypotonia and developmental delay, diagnosed as vitamin B12 deficiency. Upon he did not respond to vitamin replacement treatment, he was diagnosed with SRD by whole-exome sequencing (WES). The boy improved dramatically under treatment with L-dopa, 5-hydroxytryptophan and BH4. Conclusions: We aim to emphasize that SRD can present with nonspecific symptoms, leading to a diagnostic delay for this rare but treatable disease. Moreover, our case is the first to demonstrate the clinical benefit of BH4 add-on treatment. Early intervention is crucial for good outcome and neurodevelopment.


  • Epilepside Tanısal Yaklaşım

    by İsmail Hakkı Akbeyaz, Dilşad Türkdoğan

    Yeni teşhis edilen epilepside çocuklar ve yaşlılar en sık görülen yaş gruplarıdır. Epileptik olmayan “nöbet” terimi, epileptik nöbetlere benzeyen ancak farklı nedenlere sahip paroksismal olayları tanımlamak için kullanılmaktadır. Örneğin Psikojenik nöbetler, altta yatan çeşitli psikolojik sorunlardan kaynaklanan ve tekrarlayan, epileptik nöbetleri taklit eden paroksizmal olaylardır. Epileptik nöbetlerde EEG’nin her zaman anormal olmaması ya da EEG kaydının kas ve hareket artefaktları ile örtülü olması da tanısal süreçte yaşanan zorluklardandır. In newly diagnosed epilepsy, children and the elderly are the most common age groups. The term "nonepileptic seizure" is used to describe paroxysmal events that resemble epileptic seizures but have different underlying causes. For example, psychogenic seizures are paroxysmal events that mimic epileptic seizures and occur due to various underlying psychological issues. One of the diagnostic challenges in epileptic seizures is that the EEG is not always abnormal, or the EEG recording may be obscured by muscle and movement artifacts.

  • Open Access

    Canpolat, Temel Pediatrik Epilepsi

    by Yiğithan Güzin, Aycan Ünalp, Semra Büyükkorkmaz Öztürk, Müge Ayanoğlu, Fatma Hancı, Esma Şengenç, Sema Saltık, Hatice Hilal Kırkgöz, Burcu Karakayalı, Dilşad Türkdoğan, et al.